- All
- State-of-the-art Session
- Postgraduate Course
- Concurrent Session
- Oral Presentation
- Young Investigator Forum
- Special Session - Pediatrics Issue
- Satellite Symposium
- All
- 2022-09-16 [Friday]
- 2022-09-17 [Saturday]
- 2022-09-18 [Sunday]
- All
- Meeting Room 1
- Meeting Room 2
- Meeting Room 3
2022-09-16 Friday
Meeting Room 1 (UTC+8) 2022-09-16 Local Time
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 08:30-09:00 | 08:30-09:00 |
Reflections on the prevention and control of COVID-19 and future global pandemics |
George Fu Gao | Institute of Microbiology, Chinese Academy of Sciences |
| 09:00-09:30 | 09:00-09:30 |
Clinical and immunological features of COVID-19 : Implications for management |
Qin NING | Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology |
| 09:30-11:00 | 09:30-11:00 |
Severe acute non-A-E hepatitis in Children in 2021-2022 and managing a global response |
Philippa J. EASTERBROOK | WHO Headquarters in Geneva |
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 10:00-10:20 | 10:00-10:20 |
Global COVID-19 epidemic trend and the construction of China's public health system |
Hongzhou LU | The Third People's Hospital of Shenzhen |
| 10:20-10:40 | 10:20-10:40 |
Safety and immunogenicity of COVID-19 vaccination in patients with liver diseases |
Wenhong ZHANG | Huashan Hospital Fudan University |
| 10:40-11:00 | 10:40-11:00 |
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 |
Di WU | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 11:00-11:20 | 11:00-11:20 |
MRI evaluation of COVID-19 related brain injury MRI evaluation of COVID-19 related brain injury |
Yuanyuan Qin | Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology |
| 11:20-11:30 | 11:20-11:30 |
Panel Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 11:45-11:57 | 11:45-11:57 |
Clinical characteristics and prognosis of concomitant autoimmune hepatitis and nonalcoholic fatty liver disease |
Min ZHU | The Second Affiliated Hospital of Chongqing Medical University |
| 11:57-12:09 | 11:57-12:09 |
Human umbilical cord blood mononuclear cells ameliorate CCl4-induced acute liver injury in mice via inhibiting inflammatory responses and up-regulating peripheral interleukin-22 |
Jinming ZHANG | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine |
| 12:09-12:21 | 12:09-12:21 |
CMTM4 promotes the proliferation and metastasis of hepatocellular carcinoma through the regulation of AKT and PD-L1 |
Ziyu Chu | Fu yang Second People's Hospital |
| 12:21-12:33 | 12:21-12:33 |
Soluble Fibrinogen-Like Protein 2 Promotes the Progression of Hepatocellular Carcinoma by Inducing the Expression of Immune Checkpoints |
Meiwen HAN | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 12:45-12:57 | 12:45-12:57 |
Small extracellular vesicles derived from induced pluripotent stem cells to alleviate lipopolysaccharide /D-galactosamine induced acute liver failure |
Ying LUO | Tianjin third central hospital |
| 12:57-13:09 | 12:57-13:09 |
Significant serum proteinic and metabolic alterations in hepatitis B cirrhosis patients treated with umbilical cord mesenchymal stem cells |
Ying Shi | University of Electronic Science and Technology of China |
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 13:15-13:30 | 13:15-13:30 |
Clinical value of highly sensitive detection in CHB LLV patients |
Tao CHEN | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 13:45-14:05 | 13:45-14:05 |
Novel biomarkers for the management of chronic hepatitis B |
Yasuhito Tanaka | Department of Orthopedic Surgery, Nara Medical University |
| 14:05-14:25 | 14:05-14:25 |
Definition of HBV cure and treatment endpoint |
George Lau | Humanity & Health Medical Group/The 5th Medical Centre of Chinese PLA General Hospital |
| 14:25-14:45 | 14:25-14:45 |
Basic biology of HBV: glance over cccDNA transcription |
Wenhui LI | National Institute of Biological Sciences, Beijing |
| 14:45-15:05 | 14:45-15:05 |
Quantitative anti-HBc but not HBcrAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients |
Junliang FU | The Fifth Medical Center of Chinese PLA General Hospital |
| 15:05-15:15 | 15:05-15:15 |
Panel Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 15:30-15:42 | 15:30-15:42 |
24-week combination treatment of TLR7 agonist TQ-A3334 and PD-L1 inhibitor TQ-B2450 enhanced HBsAg reduction in NAs-suppressed CHB patients: a preliminary analysis of a phase II study (OCEANcure05) |
Ting Wu | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 15:42-15:54 | 15:42-15:54 |
Immunogenicity of Inactivated COVID-19 Vaccines in Chronic Hepatitis B Patients with Antiviral Therapy |
Wenxin WANG | Peking University 302 Clinical Medical School |
| 15:54-16:06 | 15:54-16:06 |
Lipid nanoparticle-mediated delivery of mRNA vaccine for IL-21 achieves clearance of hepatitis B virus (HBV) persistence in mouse models |
Shenyan ZHANG | Huashan hospital |
| 16:06-16:18 | 16:06-16:18 |
Subcutaneous PD-L1 Antibody ASC22 (Envafolimab) plus Nucleos(t)ide Analogs Achieved Functional Cure of Chronic Hepatitis B in 42.9% of Patients with HBsAg ≤100 IU/mL: Interim Results from a Phase IIb Clinical Trial |
Jiandan QIAN | Peking university first hospital |
| 16:18-16:30 | 16:18-16:30 |
Clinical evaluation of metagenomic next-generation sequencing method for the diagnosis of suspected ascitic infection in patients with liver cirrhosis in a clinical laboratory |
Haoxin WU | Capital medical university. Beijing youan hospital |
| 16:30-16:42 | 16:30-16:42 |
Metabolic Factors and Steatosis Increase the Risk of Adverse Outcomes in Treatment-Naïve Chronic Hepatitis B Patients with Normal Alanine Aminotransferase |
Yuting DIAO | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 16:42-16:54 | 16:42-16:54 |
High rates of HBV functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy |
Huan XIA | Tianjin Second People's Hospital |
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 17:00-17:20 | 17:00-17:20 |
Prognosis era 2.0 for HBV-ACLF |
Jun LI | The First Affiliated Hospital, College of Medicine, Zhejiang University |
| 17:20-17:40 | 17:20-17:40 |
Hepatic encephalopathy |
Rajiv JALAN | Institute for Liver and Digestive Health, UCL Medical School, London |
| 17:40-18:00 | 17:40-18:00 |
Management of acute hepatic failure |
Teerha PIRATVISUTH | NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital |
| 18:00-18:20 | 18:00-18:20 |
Management of end-stage liver disease complicated with infections |
Tao CHEN | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 18:20-18:30 | 18:20-18:30 |
Panel Discussion |
||